Next-Generation Sequencing Market Size, Share and Trends Analysis Report by Technology, by Product, by Application, by End-use, by Region and Segment Forecasts (2025 – 2032)
Global Next-Generation Sequencing Market Size was valued at USD 12.65 Bn in 2024 and is expected to reach USD 34.11 Bn by 2032, at a CAGR of 13.2% during the forecast period.
Format : PDF | Report ID : SMR_2661
Next-Generation Sequencing Market Overview
Next-generation sequencing is a modern technology that allows scientists to read and analyse DNA or RNA much faster and cheaply than old methods. It works by using a computer to break the genetic material into small pieces, sequencing them and then collecting the data. Next-generation sequencing is used to monitor medical research, disease diagnosis, cancer studies, and even infectious diseases.
The next generation sequencing market is experiencing rapid expansion due to the declining costs of sequencing, increasing personal medicine and increasing demand for genetic testing in oncology and rare diseases. Technological progress, such as long-reading sequencing, portable sequences and AI-operated data analysis, are comprehensive by next-generation sequencing applications. The next generation sequencing market has observed important innovations due to the demand for sharp, more accurate and cost -effective genomic analysis. One major breakthrough is the rise of long-read sequencing technologies, such as PacBio’s HiFi sequencing and Oxford Nanopore’s ultra-long reads, which enhance the detection of complex genomic variants and improve genome assembly.
According to the U.S. International Trade Commission (USITC), the U.S. maintains low tariffs (0-3%) on Next-Generation Sequencing equipment and reagents, as they are classified under essential medical goods, facilitating global trade. This policy supports the dominance of U.S. firms like Illumina and Thermo Fisher in exports while ensuring affordable imports of critical components from Germany and China.
To get more Insights: Request Free Sample Report
Next-Generation Sequencing Market Dynamics
Rising Demand for Precision Medicine & Tech Advancements to Propel Next-Generation Sequencing Market Growth
Global next generation sequencing market has seen significant expansion in accurate medicine and widespread government support for growing applications and genomic research. The American NIH has greatly increased its genomics research budget, while the UK government has continued its national genome sequencing initiative through NHS. Technological innovations are transforming the field, with Illumina's high-throughput systems and Oxford Nanopore's portable devices enabling faster, more accessible sequencing. Major research projects such as Genomeindia in India and accurate medical programs of China are moving forward. Major regulatory agencies report that next generation sequencing has become necessary for modern diagnosis, especially in oncology and rare disease research. These developments outline the important role of NGS in pursuing personal healthcare worldwide.
In addition, portable sequences and AI-operated data analysis increase technological progress, efficiency, and scalability. The collaboration between biotech firms, hospitals, and research institutes also motivates innovation, while increasing application of next generation sequencing in non-medical fields (agriculture, forensics) expands its market capacity.
Shortage of Skilled Personnel in Developing Countries to Obstruct Next-Generation Sequencing Market Growth
The global next generation sequencing market has seen significant growth due to the growing use of these techniques worldwide. Also, the market growth is slightly limited by some factors such as a lack of skilled personnel with the knowledge required to handle this advanced equipment in developing countries. Along with this, the need for high investment in research projects that help to enhance market development.
Apart from this, the challenges associated with secure storage of large volumes of generated data is another concern, limiting market growth to a certain extent. A large amount of data is generated through various genome projects. It is not economically feasible for many research institutes and biopharmaceutical companies to successfully and securely store this data. Thus, issues regarding the safe storage of this data are impeding next generation sequencing industry growth.
Increasing use of genomics in precision medicine helps to boost the Next-Generation Sequencing Market
Increasing use of genomics in priced medicine is greatly increasing the next generation sequencing market, as it enables analogous treatments based on individual genetic profiles. The next generation sequencing allows for rapid, cost-effective analysis of large genomic datasets, which makes it necessary to develop disease-causing mutations and targeted treatments. Increasing demand for personal medicine, especially in oncology and rare genetic disorders, next generation sequencing is being adopted. Additionally, progress in biochemistry and AI-operated data analysis is increasing the clinical utility of next-generation sequencing. The government's initiative for genomic research and the funding accelerates the development of the next-generation sequencing market.
Next-Generation Sequencing Market Segment Analysis
Based on Technology, the target sequencing and resequencing segment held the largest market share in 2024. This section is expected to increase demand after the increase of the entire genome sequencing, as the availability of a large amount of whole genome data need to be analysed for specific gene places and different genetic expressions. Many companies in the next-generation sequencing market offer targeted sequencing services. Thus, this section is expected to grow in association with the WGS section during the forecast period. Targeted sequencing panels are expected to remain workhorses for molecular diagnosis, and they are expected to become a regular part of the management of haem and solid tumours.
Based on Product, the Reagents and consumable materials dominated the next-generation sequencing market in 2024 and accounting for the largest revenue stake due to their recurring demand in sequencing workflows. As Next-generation sequencing adoption increases in research and diagnosis and requirement for high-quality kits, enzymes, and library preparations increases. This section is carried by continuous innovations such as targeted sequencing panels and automation-compatible, and it is essential for both clinical and research applications.
Also, the Instruments is the second largest segment due to some development in sequencer technology, including benchtops and high-throughput systems. While devices require significant upfront investment, their demand is increasing with genomic research and the expansion of clinical laboratories.
Next-Generation Sequencing Market Regional Analysis
North America to Lead Next-Generation Sequencing Market with Advanced Technology and Strong Investments
North American region currently dominates the next generation sequencing market due to its widely adoption in advanced healthcare infrastructure, strong research funding and accurate therapy. The presence of major biotechnology and pharmaceutical companies with important government and private investments in genomics research further strengthens its position. Additionally, the U.S. Prominent next generation sequencing technology providers, such as Illumina and Thermo Fisher are home to promote scientists, innovation and access. High awareness of genetic testing and favorable reimbursement policies also contribute to the development of the market. Europe follows closely, but next-generation sequencing technologies and strong educational industry cooperations strengthen its leadership in the global next-generation sequencing market by early adoption of North America.
Next-Generation Sequencing Market Competitive Landscape
The next-generation sequencing market players, such as Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences and BGI genomics is heavily investing in research and development to expand their product lines, which help to grow the next generation sequencing market. Market participants are working on various strategic activities to expand their global tracks including significant market developments such as new product launches, contractual agreements, mergers and acquisitions, high investment and collaboration with other organisations to expand and survive in the competitive and growing next-generation sequencing market.
Next generation sequencing market Recent Developments
- Illumina - NovaSeq X Plus (January 2024) Launched as the fastest, most cost-efficient high-throughput sequencer, capable of sequencing a whole human genome for under $200 in less than 16 hours.
- Thermo Fisher Scientific - Ion GeneStudio S5 Prime (March 2024) Introduced enhanced semiconductor sequencing with improved SNP and CNV detection, targeting clinical and translational research markets.
Next-Generation Sequencing Market Scope |
|
Market Size in 2024 |
USD 12.65 Bn |
Market Size in 2032 |
USD 34.11 Bn |
CAGR (2025-2032) |
13.2 % |
Historic Data |
2019-2024 |
Base Year |
2024 |
Forecast Period |
2025-2032 |
Segments |
By Technology Whole Genome Sequencing Targeted Sequencing & Re-sequencing Whole Exome Sequencing RNA Sequencing De Novo Sequencing Other |
By Product Instruments Reagents & Consumables Services |
|
By Application Drug Discovery/Personalized Medicine Genetic Screening Diagnostics/Infectious Diseases Agricultural & Animal Research Others |
|
By End-User Healthcare Institutions Academics Biotech & Pharma Firms Others |
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East South America – Brazil, Argentina, Rest of South America |
Key Players in the Next-Generation Sequencing Market are:
North America:
- Illumina, Inc. (San Diego, California, USA)
- Thermo Fisher Scientific Inc. (Waltham, Massachusetts, USA)
- Pacific Biosciences of California, Inc. (PacBio) (Menlo Park, California, USA)
- Agilent Technologies, Inc. (Santa Clara, California, USA)
- PerkinElmer Inc. (Waltham, Massachusetts, USA)
- Bio-Rad Laboratories, Inc. (Hercules, California, USA)
- Danaher Corporation (Washington, D.C., USA)
- 10x Genomics, Inc. (Pleasanton, California, USA)
- GeneDx (Stamford, Connecticut, USA)
- Illumina, Inc. (San Diego, California, USA)
Europe:
- Oxford Nanopore Technologies plc. (Oxford, United Kingdom)
- QIAGEN N.V. (Hilden, Germany)
- F. Hoffmann-La Roche Ltd. (Basel, Switzerland)
- Eurofins Scientific (Luxembourg City, Luxembourg)
- Novogene (Europe) (Cambridge, United Kingdom)
- LGC Biosearch Technologies (Teddington, United Kingdom)
- Macrogen Europe (Amsterdam, Netherlands)
- Genewiz (Azenta Life Sciences) (Leipzig, Germany)
Asia-Pacific:
- BGI Group (Shenzhen, China)
- Macrogen Inc. (Seoul, South Korea)
- Novogene (Beijing, China)
- Takara Bio Inc. (Kusatsu, Japan)
- GenScript Biotech Corporation (Nanjing, China)
- Natera, Inc. (Singapore)
Middle East and Africa:
- LifeQ (Johannesburg, South Africa)
- Inqaba Biotechnical Industries (Pty) Ltd (Pretoria, South Africa)
South America:
- Dasa S.A. (São Paulo, Brazil)
- Mendelics Análise Genômica (São Paulo, Brazil)
- Genera (São Paulo, Brazil)
Frequently Asked Questions
Ans: The global Next-Generation Sequencing market was USD 12.65 billion in 2024.
Ans: The Global Next-Generation Sequencing Market is divided into Technology, Product, Application and End-user.
Ans: The Europe region will be the fastest growing in the Next-Generation Sequencing Market during the forecast period.
Ans: The top players in the Next-Generation Sequencing market are Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Agilent Technologies, Inc. and PerkinElmer Inc.
1. Next-Generation Sequencing Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Next-Generation Sequencing Market: Competitive Landscape
2.1. SMR Competition Matrix
2.2. Key Players Benchmarking
2.2.1. Company Name
2.2.2. Service Segment
2.2.3. End-User Segment
2.2.4. Revenue (2024)
2.2.5. Geographical Presence
2.3. Market Structure
2.3.1. Market Leaders
2.3.2. Market Followers
2.3.3. Emerging Players
2.4. Mergers and Acquisitions Details
3. Next-Generation Sequencing Market: Dynamics
3.1. Next-Generation Sequencing Market Trends
3.2. Next-Generation Sequencing Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PORTER’s Five Forces Analysis
3.4. PESTLE Analysis
3.5. Regulatory Landscape by Region
3.6. Key Opinion Leader Analysis for the Global Industry
3.7. Analysis of Government Schemes and Initiatives for Industry
4. Next-Generation Sequencing Market: Global Market Size and Forecast by Segmentation (by Value in USD Billion) (2025-2032)
4.1. Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
4.1.1. Whole Genome Sequencing
4.1.2. Targeted Sequencing & Re-sequencing
4.1.3. Whole Exome Sequencing
4.1.4. RNA Sequencing
4.1.5. De Novo Sequencing
4.1.6. Other
4.2. Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
4.2.1. Instruments
4.2.2. Reagents & Consumables
4.2.3. Services
4.3. Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
4.3.1. Drug Discovery/Personalized Medicine
4.3.2. Genetic Screening
4.3.3. Diagnostics/Infectious Diseases
4.3.4. Agricultural & Animal Research
4.3.5. Others
4.4. Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
4.4.1. Healthcare Institutions
4.4.2. Academics
4.4.3. Biotech & Pharma Firms
4.4.4. Others
4.5. Next-Generation Sequencing Market Size and Forecast, By Region (2025-2032)
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. North America Next-Generation Sequencing Market Size and Forecast by Segmentation (by Value in USD Billion) (2025-2032)
5.1. North America Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
5.1.1. Whole Genome Sequencing
5.1.2. Targeted Sequencing & Re-sequencing
5.1.3. Whole Exome Sequencing
5.1.4. RNA Sequencing
5.1.5. De Novo Sequencing
5.1.6. Other
5.2. North America Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
5.2.1. Instruments
5.2.2. Reagents & Consumables
5.2.3. Services
5.3. North America Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
5.3.1. Drug Discovery/Personalized Medicine
5.3.2. Genetic Screening
5.3.3. Diagnostics/Infectious Diseases
5.3.4. Agricultural & Animal Research
5.3.5. Others
5.4. North America Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
5.4.1. Healthcare Institutions
5.4.2. Academics
5.4.3. Biotech & Pharma Firms
5.4.4. Others
5.5. North America Next-Generation Sequencing Market Size and Forecast, by Country (2025-2032)
5.5.1. United States
5.5.1.1. United States Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
5.5.1.1.1. Whole Genome Sequencing
5.5.1.1.2. Targeted Sequencing & Re-sequencing
5.5.1.1.3. Whole Exome Sequencing
5.5.1.1.4. RNA Sequencing
5.5.1.1.5. De Novo Sequencing
5.5.1.1.6. Other
5.5.1.2. United States Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
5.5.1.2.1. Instruments
5.5.1.2.2. Reagents & Consumables
5.5.1.2.3. Services
5.5.1.3. United States Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
5.5.1.3.1. Drug Discovery/Personalized Medicine
5.5.1.3.2. Genetic Screening
5.5.1.3.3. Diagnostics/Infectious Diseases
5.5.1.3.4. Agricultural & Animal Research
5.5.1.3.5. Others
5.5.1.4. United States Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
5.5.1.4.1. Healthcare Institutions
5.5.1.4.2. Academics
5.5.1.4.3. Biotech & Pharma Firms
5.5.1.4.4. Others
5.5.2. Canada
5.5.2.1. Canada Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
5.5.2.1.1. Whole Genome Sequencing
5.5.2.1.2. Targeted Sequencing & Re-sequencing
5.5.2.1.3. Whole Exome Sequencing
5.5.2.1.4. RNA Sequencing
5.5.2.1.5. De Novo Sequencing
5.5.2.1.6. Other
5.5.2.2. Canada Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
5.5.2.2.1. Instruments
5.5.2.2.2. Reagents & Consumables
5.5.2.2.3. Services
5.5.2.3. Canada Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
5.5.2.3.1. Drug Discovery/Personalized Medicine
5.5.2.3.2. Genetic Screening
5.5.2.3.3. Diagnostics/Infectious Diseases
5.5.2.3.4. Agricultural & Animal Research
5.5.2.3.5. Others
5.5.2.4. Canada Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
5.5.2.4.1. Healthcare Institutions
5.5.2.4.2. Academics
5.5.2.4.3. Biotech & Pharma Firms
5.5.2.4.4. Others
5.5.3. Mexico
5.5.3.1. Mexico Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
5.5.3.1.1. Whole Genome Sequencing
5.5.3.1.2. Targeted Sequencing & Re-sequencing
5.5.3.1.3. Whole Exome Sequencing
5.5.3.1.4. RNA Sequencing
5.5.3.1.5. De Novo Sequencing
5.5.3.1.6. Other
5.5.3.2. Mexico Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
5.5.3.2.1. Instruments
5.5.3.2.2. Reagents & Consumables
5.5.3.2.3. Services
5.5.3.3. Mexico Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
5.5.3.3.1. Drug Discovery/Personalized Medicine
5.5.3.3.2. Genetic Screening
5.5.3.3.3. Diagnostics/Infectious Diseases
5.5.3.3.4. Agricultural & Animal Research
5.5.3.3.5. Others
5.5.3.4. Mexico Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
5.5.3.4.1. Healthcare Institutions
5.5.3.4.2. Academics
5.5.3.4.3. Biotech & Pharma Firms
5.5.3.4.4. Others
6. Europe Next-Generation Sequencing Market Size and Forecast by Segmentation (by Value in USD Billion) (2025-2032)
6.1. Europe Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.2. Europe Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.3. Europe Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.4. Europe Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5. Europe Next-Generation Sequencing Market Size and Forecast, by Country (2025-2032)
6.5.1. United Kingdom
6.5.1.1. United Kingdom Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.1.2. United Kingdom Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.1.3. United Kingdom Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.1.4. United Kingdom Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5.2. France
6.5.2.1. France Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.2.2. France Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.2.3. France Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.2.4. France Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5.3. Germany
6.5.3.1. Germany Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.3.2. Germany Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.3.3. Germany Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.3.4. Germany Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5.4. Italy
6.5.4.1. Italy Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.4.2. Italy Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.4.3. Italy Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.4.4. Italy Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5.5. Spain
6.5.5.1. Spain Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.5.2. Spain Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.5.3. Spain Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.5.4. Spain Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5.6. Sweden
6.5.6.1. Sweden Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.6.2. Sweden Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.6.3. Sweden Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.6.4. Sweden Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5.7. Russia
6.5.7.1. Russia Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.7.2. Russia Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.7.3. Russia Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.7.4. Russia Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
6.5.8. Rest of Europe
6.5.8.1. Rest of Europe Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
6.5.8.2. Rest of Europe Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
6.5.8.3. Rest of Europe Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
6.5.8.4. Rest of Europe Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7. Asia Pacific Next-Generation Sequencing Market Size and Forecast by Segmentation (by Value in USD Billion) (2025-2032)
7.1. Asia Pacific Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.2. Asia Pacific Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.3. Asia Pacific Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.4. Asia Pacific Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5. Asia Pacific Next-Generation Sequencing Market Size and Forecast, by Country (2025-2032)
7.5.1. China
7.5.1.1. China Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.1.2. China Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.1.3. China Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.1.4. China Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.2. S Korea
7.5.2.1. S Korea Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.2.2. S Korea Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.2.3. S Korea Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.2.4. S Korea Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.3. Japan
7.5.3.1. Japan Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.3.2. Japan Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.3.3. Japan Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.3.4. Japan Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.4. India
7.5.4.1. India Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.4.2. India Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.4.3. India Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.4.4. India Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.5. Australia
7.5.5.1. Australia Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.5.2. Australia Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.5.3. Australia Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.5.4. Australia Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.6. Indonesia
7.5.6.1. Indonesia Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.6.2. Indonesia Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.6.3. Indonesia Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.6.4. Indonesia Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.7. Malaysia
7.5.7.1. Malaysia Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.7.2. Malaysia Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.7.3. Malaysia Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.7.4. Malaysia Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.8. Philippines
7.5.8.1. Philippines Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.8.2. Philippines Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.8.3. Philippines Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.8.4. Philippines Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.9. Thailand
7.5.9.1. Thailand Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.9.2. Thailand Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.9.3. Thailand Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.9.4. Thailand Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.10. Vietnam
7.5.10.1. Vietnam Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.10.2. Vietnam Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.10.3. Vietnam Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.10.4. Vietnam Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
7.5.11. Rest of Asia Pacific
7.5.11.1. Rest of Asia Pacific Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
7.5.11.2. Rest of Asia Pacific Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
7.5.11.3. Rest of Asia Pacific Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
7.5.11.4. Rest of Asia Pacific Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
8. Middle East and Africa Next-Generation Sequencing Market Size and Forecast (by Value in USD Billion) (2024-2032
8.1. Middle East and Africa Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
8.2. Middle East and Africa Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
8.3. Middle East and Africa Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
8.4. Middle East and Africa Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
8.5. Middle East and Africa Next-Generation Sequencing Market Size and Forecast, by Country (2025-2032)
8.5.1. South Africa
8.5.1.1. South Africa Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
8.5.1.2. South Africa Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
8.5.1.3. South Africa Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
8.5.1.4. South Africa Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
8.5.2. GCC
8.5.2.1. GCC Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
8.5.2.2. GCC Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
8.5.2.3. GCC Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
8.5.2.4. GCC Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
8.5.3. Egypt
8.5.3.1. Egypt Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
8.5.3.2. Egypt Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
8.5.3.3. Egypt Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
8.5.3.4. Egypt Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
8.5.4. Nigeria
8.5.4.1. Nigeria Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
8.5.4.2. Nigeria Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
8.5.4.3. Nigeria Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
8.5.4.4. Nigeria Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
8.5.5. Rest of ME&A
8.5.5.1. Rest of ME&A Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
8.5.5.2. Rest of ME&A Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
8.5.5.3. Rest of ME&A Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
8.5.5.4. Rest of ME&A Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
9. South America Next-Generation Sequencing Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032
9.1. South America Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
9.2. South America Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
9.3. South America Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
9.4. South America Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
9.5. South America Next-Generation Sequencing Market Size and Forecast, by Country (2025-2032)
9.5.1. Brazil
9.5.1.1. Brazil Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
9.5.1.2. Brazil Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
9.5.1.3. Brazil Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
9.5.1.4. Brazil Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
9.5.2. Argentina
9.5.2.1. Argentina Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
9.5.2.2. Argentina Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
9.5.2.3. Argentina Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
9.5.2.4. Argentina Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
9.5.3. Colombia
9.5.3.1. Colombia Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
9.5.3.2. Colombia Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
9.5.3.3. Colombia Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
9.5.3.4. Colombia Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
9.5.4. Chile
9.5.4.1. Chile Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
9.5.4.2. Chile Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
9.5.4.3. Chile Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
9.5.4.4. Chile Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
9.5.5. Rest Of South America
9.5.5.1. Rest Of South America Next-Generation Sequencing Market Size and Forecast, By Technology (2025-2032)
9.5.5.2. Rest Of South America Next-Generation Sequencing Market Size and Forecast, By Product (2025-2032)
9.5.5.3. Rest Of South America Next-Generation Sequencing Market Size and Forecast, By Application (2025-2032)
9.5.5.4. Rest Of South America Next-Generation Sequencing Market Size and Forecast, By End-User (2025-2032)
10. Company Profile: Key Players
10.1. Illumina, Inc. (San Diego, California, USA)
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Recent Developments
10.2. Thermo Fisher Scientific Inc. (Waltham, Massachusetts, USA)
10.3. Pacific Biosciences of California, Inc. (PacBio) (Menlo Park, California, USA)
10.4. Agilent Technologies, Inc. (Santa Clara, California, USA)
10.5. PerkinElmer Inc. (Waltham, Massachusetts, USA)
10.6. Bio-Rad Laboratories, Inc. (Hercules, California, USA)
10.7. Danaher Corporation (Washington, D.C., USA)
10.8. 10x Genomics, Inc. (Pleasanton, California, USA)
10.9. GeneDx (Stamford, Connecticut, USA)
10.10. Illumina, Inc. (San Diego, California, USA)
10.11. Oxford Nanopore Technologies plc. (Oxford, United Kingdom)
10.12. QIAGEN N.V. (Hilden, Germany)
10.13. F. Hoffmann-La Roche Ltd. (Basel, Switzerland)
10.14. Eurofins Scientific (Luxembourg City, Luxembourg)
10.15. Novogene (Europe) (Cambridge, United Kingdom)
10.16. LGC Biosearch Technologies (Teddington, United Kingdom)
10.17. Macrogen Europe (Amsterdam, Netherlands)
10.18. Genewiz (Azenta Life Sciences) (Leipzig, Germany)
10.19. BGI Group (Shenzhen, China)
10.20. Macrogen Inc. (Seoul, South Korea)
10.21. Novogene (Beijing, China)
10.22. Takara Bio Inc. (Kusatsu, Japan)
10.23. GenScript Biotech Corporation (Nanjing, China)
10.24. Natera, Inc. (Singapore)
10.25. LifeQ (Johannesburg, South Africa)
10.26. Inqaba Biotechnical Industries (Pty) Ltd (Pretoria, South Africa)
10.27. Dasa S.A. (São Paulo, Brazil)
10.28. Mendelics Análise Genômica (São Paulo, Brazil)
10.29. Genera (São Paulo, Brazil)
11. Key Findings
12. Industry Recommendations
13. Next-Generation Sequencing Market: Research Methodolog